Christina E. Wang
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Christina E. Wang has a total of 39 co-authors. Here are the top co-authors by number of shared publications:
- Alexandre F. Carisey
Department of Cell and Molecular Biology, St. Jude Children’s Research Hospital, Memphis, TN 38105, USA
1 shared publication - Alissa DuPuy Guarnaccia
Department of Discovery Oncology, Genentech, South San Francisco, CA, USA
1 shared publication - Amanda Johnson
Center for Cell and Tissue Imaging, St. Jude Children’s Research Hospital, Memphis, TN 38105, USA
1 shared publication - April M. Weissmiller
Department of Biology, Middle Tennessee State University, Murfreesboro, TN 37132, USA
1 shared publication - Baranda S. Hansen
Center for Advanced Genome Engineering, Department of Cell and Molecular Biology, St. Jude Children’s Research Hospital, Memphis, USA
1 shared publication Bin Zhao
Department of Biochemistry, Vanderbilt University School of Medicine, Nashville, TN 37232, USA
1 shared publication
Latest Publications
- Open Access
- 10 June 2024
- Published by Rockefeller University Press in Journal of Cell Biology
- Vol. 223 (9)
Sonic Hedgehog activates prostaglandin signaling to stabilize primary cilium length
Sonic Hedgehog (SHH) is a driver of embryonic patterning that, when corrupted, triggers developmental disorders and cancers. SHH effector responses are organized through primary cilia (PC) that grow and retract with the cell cycle and in response to extracellular cues. Disruption of PC homeostasis corrupts SHH regulation, placing significant pressure on the pathway to maintain ciliary fitness. Mechanisms by which ciliary robustness is ensured in SHH-stimulated cells are not yet known. Herein, we reveal a crosstalk circuit induced by SHH activation of Phospholipase A2α that drives ciliary E-type prostanoid receptor 4 (EP4) signaling to ensure PC function and stabilize ciliary length. We demonstrate that blockade of SHH-EP4 crosstalk destabilizes PC cyclic AMP (cAMP) equilibrium, slows ciliary transport, reduces ciliary length, and attenuates SHH pathway induction. Accordingly, Ep4−/− mice display shortened neuroepithelial PC and altered SHH-dependent neuronal cell fate specification. Thus, SHH initiates coordination between distinct ciliary receptors to maintain PC function and length homeostasis for robust downstream signaling.
- 10 June 2024
- Published by Rockefeller University Press in Journal of Cell Biology
- Vol. 223 (9)
Open AccessSonic Hedgehog activates prostaglandin signaling to stabilize primary cilium length
Sonic Hedgehog (SHH) is a driver of embryonic patterning that, when corrupted, triggers developmental disorders and cancers. SHH effector responses are organized through primary cilia (PC) that grow and retract with the cell cycle and in response to extracellular cues. Disruption of PC homeostasis corrupts SHH regulation, placing significant pressure on the pathway to maintain ciliary fitness. Mechanisms by which ciliary robustness is ensured in SHH-stimulated cells are not yet known. Herein, we reveal a crosstalk circuit induced by SHH activation of Phospholipase A2α that drives ciliary E-type prostanoid receptor 4 (EP4) signaling to ensure PC function and stabilize ciliary length. We demonstrate that blockade of SHH-EP4 crosstalk destabilizes PC cyclic AMP (cAMP) equilibrium, slows ciliary transport, reduces ciliary length, and attenuates SHH pathway induction. Accordingly, Ep4−/− mice display shortened neuroepithelial PC and altered SHH-dependent neuronal cell fate specification. Thus, SHH initiates coordination between distinct ciliary receptors to maintain PC function and length homeostasis for robust downstream signaling.
- Open Access
- 22 September 2021
- Published by Frontiers Media SA in Frontiers in Cardiovascular Medicine
- Vol. 8
Intravascular Lithotripsy-Assisted Transfemoral TAVI: The Copenhagen Experience and Literature Review
Transcatheter aortic valve implantation (TAVI) is currently an established therapy for elderly patients with symptomatic severe aortic valve stenosis across all surgical risk categories. Access is an important aspect when planning for and performing TAVI. The superiority of a transfemoral (TF) approach compared to a transthoracic (transapical, direct aortic) approach has been demonstrated in several studies. Recently, the introduction of intravascular lithotripsy (IVL) has made it possible to treat patients with calcified iliofemoral disease by TF approach. This article aimed to provide a comprehensive overview on the following aspects: (1) preprocedural planning for IVL-assisted TF-TAVI; (2) procedural aspects in IVL-assisted TF-TAVI; (3) outcomes of IVL-assisted TF-TAVI in an experienced TAVI center; and (4) literature review and discussion of this new emerging approach.
- 22 September 2021
- Published by Frontiers Media SA in Frontiers in Cardiovascular Medicine
- Vol. 8
Open AccessIntravascular Lithotripsy-Assisted Transfemoral TAVI: The Copenhagen Experience and Literature Review
Transcatheter aortic valve implantation (TAVI) is currently an established therapy for elderly patients with symptomatic severe aortic valve stenosis across all surgical risk categories. Access is an important aspect when planning for and performing TAVI. The superiority of a transfemoral (TF) approach compared to a transthoracic (transapical, direct aortic) approach has been demonstrated in several studies. Recently, the introduction of intravascular lithotripsy (IVL) has made it possible to treat patients with calcified iliofemoral disease by TF approach. This article aimed to provide a comprehensive overview on the following aspects: (1) preprocedural planning for IVL-assisted TF-TAVI; (2) procedural aspects in IVL-assisted TF-TAVI; (3) outcomes of IVL-assisted TF-TAVI in an experienced TAVI center; and (4) literature review and discussion of this new emerging approach.
- Open Access
- 1 January 2021
- Published by Elsevier in Cell Reports
- Vol. 34 (3) , 108636
Impact of WIN site inhibitor on the WDR5 interactome
- 1 January 2021
- Published by Elsevier in Cell Reports
- Vol. 34 (3) , 108636
Open AccessImpact of WIN site inhibitor on the WDR5 interactome